M & As this week: CSL, Sunflower Pharmaceutical Group, Immunotech Laboratories

Australian biotherapeutics company CSL has reached an agreement with Chinese healthcare company Humanwell Healthcare Group to acquire an 80% equity stake in the latter ’s subsidiary, Wuhan Zhong Yuan Rui De Biological Products (Ruide).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: